Cash Flow JCR Pharmaceuticals Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
3,224.00
-5,983.00
7,244.00
5,412.00
19,404.00
8,653.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-6,227.00
-1,063.00
-3,538.00
-3,843.00
-9,173.00
588.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-135.00
-5,791.00
9,312.00
-5,500.00
9,289.00
10,341.00
Cash Flow from Investing Activities
-12,504.00
-9,569.00
-2,690.00
-15,002.00
-3,250.00
-3,290.00
Cash Flow from Financing Activities
13,305.00
9,736.00
-2,031.00
1,948.00
-2,179.00
8,304.00
Net Cash Inflow / Outflow
811.00
-5,560.00
5,477.00
-17,455.00
4,472.00
15,333.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
145.00
64.00
886.00
1,099.00
612.00
-22.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of JCR Pharmaceuticals Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
3224
14273
-11,049.00
-77.41%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-6227
-23409
17,182.00
73.40%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-135
7433
-7,568.00
-101.82%
Cash Flow from Investing Activities
-12504
-22898
10,394.00
45.39%
Cash Flow from Financing Activities
13305
5587
7,718.00
138.14%
Net Cash Inflow / Outflow
811
-9796
10,607.00
108.28%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
145
82
63.00
76.83%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 97.67% vs -162.19% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-135.00
-5,791.00
97.67%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
